Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Sep;30(9):812–816. doi: 10.1136/jcp.30.9.812

Beta-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia.

G A Pangalis, X Yataganas, P Fessas
PMCID: PMC476565  PMID: 303244

Abstract

beta-Glucuronidase activity was semiquantitatively estimated in the cells of lymph node (LN) imprints from patients with Hodgkin's disease (HD), diffuse non-Hodgkin's lymphomas, chronic lymphocytic leukaemia (CLL), normal lymph nodes, and benign lymphadenopathies. In addition, in some of these cases beta-glucuronidase activity was semiquantitatively determined in peripheral blood smear lymphocytes. The beta-glucuronidase score (betaGS) was very low in the cells of the LN imprints from patients with diffuse non-Hodgkin's lymphomas. The LN lymphocytes of HD had a normal betaGS independently of the histological subtype of the disease, while in the LN imprint of CLL the enzyme activity was low, normal, or high. The betaGS of the lymphocytes in LN imprints of normal controls and HD were in general significantly lower compared with he lymphocytes of the peripheral blood smears in the same cases. The relation of our findings to the B and T cell origin of malignant lymphomas and chronic lymphocytic leukaemia is discussed.

Full text

PDF
812

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANLYAN A. J., GAMBLE J., HOSTER H. A. Beta-glucuronidase activity of the white blood cells in human leukemias and Hodgkin's disease. Cancer. 1950 Jan;3(1):116–123. doi: 10.1002/1097-0142(1950)3:1<116::aid-cncr2820030114>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  2. Aisenberg A. C., Long J. C. Lymphocyte surface characteristics in malignant lymphoma. Am J Med. 1975 Mar;58(3):300–306. doi: 10.1016/0002-9343(75)90595-1. [DOI] [PubMed] [Google Scholar]
  3. Braylan R. C., Jaffe E. S., Burbach J. W., Frank M. M., Johnson R. E., Berard C. W. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res. 1976 May;36(5):1619–1625. [PubMed] [Google Scholar]
  4. Brittinger G., König E., Aberle H. G., Zimmerschitt E. Lysosomale Enzyme in Blutlymphozyten von Gesunden und Patienten mit chronischer Lymphadenose bei kurzdauernder unspezifischer Stimulierung in vitro. Schweiz Med Wochenschr. 1970 Feb 14;100(7):341–344. [PubMed] [Google Scholar]
  5. Brouet J. C., Sasportes M., Flandrin G., Preud'Homme J. L., Seligmann M. Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet. 1975 Nov 8;2(7941):890–893. doi: 10.1016/s0140-6736(75)92127-3. [DOI] [PubMed] [Google Scholar]
  6. Catovsky D., Galetto J., Okos A., Miliani E., Galton D. A. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol. 1974 Oct;27(10):767–771. doi: 10.1136/jcp.27.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Catovsky D. Letter: T-cell origin of acid-phosphatase-positive lymphoblasts. Lancet. 1975 Aug 16;2(7929):327–328. doi: 10.1016/s0140-6736(75)92767-1. [DOI] [PubMed] [Google Scholar]
  8. Catovsky D., Miliani E., Okos A., Galton D. A. Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet. 1974 Sep 28;2(7883):751–752. doi: 10.1016/s0140-6736(74)90944-1. [DOI] [PubMed] [Google Scholar]
  9. Crowder J. G., White A. C. Selective changes in white cell lysosomal enzymes in man. Am J Med Sci. 1968 May;255:327–335. doi: 10.1097/00000441-196805000-00008. [DOI] [PubMed] [Google Scholar]
  10. Davis S. The variable pattern of circulating lymphocyte subpopulations in chronic lymphocytic leukemia. N Engl J Med. 1976 May 20;294(21):1150–1153. doi: 10.1056/NEJM197605202942104. [DOI] [PubMed] [Google Scholar]
  11. Douglas S. D., Cohnen G., König E., Brittinger G. Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood. 1973 Apr;41(4):511–518. [PubMed] [Google Scholar]
  12. FOLLETTE J. H., VALENTINE W. N., LAWRENCE J. S. The beta glucuronidase content of human leukocytes in health and in disease. J Lab Clin Med. 1952 Dec;40(6):825–840. [PubMed] [Google Scholar]
  13. Flandrin G., Daniel M. T. Beta-glucuronidase activity in Sezary cells. Scand J Haematol. 1974;12(1):23–31. doi: 10.1111/j.1600-0609.1974.tb00176.x. [DOI] [PubMed] [Google Scholar]
  14. HAYASHI M., NAKAJIMA Y., FISHMAN W. H. THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT. J Histochem Cytochem. 1964 Apr;12:293–297. doi: 10.1177/12.4.293. [DOI] [PubMed] [Google Scholar]
  15. Lorbacher P., Yam L. T., Mitus W. J. Cytochemical demonstration of beta-glucuronidase activity in blood and bone marrow cells. J Histochem Cytochem. 1967 Aug;15(11):680–687. doi: 10.1177/15.11.680. [DOI] [PubMed] [Google Scholar]
  16. Nathwani B. N., Kim H., Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976 Aug;38(2):964–983. doi: 10.1002/1097-0142(197608)38:2<964::aid-cncr2820380248>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  17. Pangalis G. A., Nathwani B. N., Rappaport H. Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström. Cancer. 1977 Mar;39(3):999–1010. doi: 10.1002/1097-0142(197703)39:3<999::aid-cncr2820390302>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  18. Platt D., Platt M. Biochemischer und histochemischer Nachweis der beta-Glukuronidase und beta-azetylglukosaminidase in normalen und pathologisch veränderten menschlichen Lymphknoten. Blut. 1971 Jan;22(1):12–18. doi: 10.1007/BF01633623. [DOI] [PubMed] [Google Scholar]
  19. Ritter J., Gaedicke G., Winkler K., Beckmann H., Landbeck G. Letter: Possible T-cell origin of lymphoblasts in acid-phosphatase-positive acute lymphatic leukaemia. Lancet. 1975 Jul 12;2(7924):75–75. doi: 10.1016/s0140-6736(75)90515-2. [DOI] [PubMed] [Google Scholar]
  20. Stein H., Lennert K., Parwaresch M. R. Malignant lymphomas of B-cell type. Lancet. 1972 Oct 21;2(7782):855–857. doi: 10.1016/s0140-6736(72)92215-5. [DOI] [PubMed] [Google Scholar]
  21. Tamaoki N., Essner E. Distribution of acid phosphatase, beta-glucuronidase and N-acetyl-beta-glucosaminise activities in lymphocytes of lymphatic tissues of man and rodents. J Histochem Cytochem. 1969 Apr;17(4):238–243. doi: 10.1177/17.4.238. [DOI] [PubMed] [Google Scholar]
  22. Wehinger H., Möbius W. Cytochemical studies on T and B lymphocytes and lymphoblasts with special reference to acid phosphatase. Acta Haematol. 1976;56(3):129–136. doi: 10.1159/000207929. [DOI] [PubMed] [Google Scholar]
  23. Westerhausen M. Constatations cytochimiques et immunologiques dans les leucémies lymphoïdes chroniques (L.L.C. Nouv Rev Fr Hematol. 1973 May-Jun;13(3):398–400. [PubMed] [Google Scholar]
  24. Woessner S., Millá F., Rozman C. A study of lymphocytic beta-glucuronidase in various benign and malignant lymphatic processes. Acta Haematol. 1974;51(2):84–90. doi: 10.1159/000208280. [DOI] [PubMed] [Google Scholar]
  25. Yam L. T., Mitus W. J. The lymphocyte beta-glucuronidase activity in lymphoproliferative disorders. Blood. 1968 Apr;31(4):480–489. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES